rs147843540

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001292063.2(OTOG):​c.996+9C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00952 in 1,550,518 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0071 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0098 ( 77 hom. )

Consequence

OTOG
NM_001292063.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.624

Publications

0 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-17558324-C-A is Benign according to our data. Variant chr11-17558324-C-A is described in ClinVar as Benign. ClinVar VariationId is 226858.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00705 (1074/152330) while in subpopulation NFE AF = 0.0113 (772/68018). AF 95% confidence interval is 0.0107. There are 9 homozygotes in GnomAd4. There are 540 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGNM_001292063.2 linkc.996+9C>A intron_variant Intron 9 of 55 ENST00000399397.6 NP_001278992.1
OTOGNM_001277269.2 linkc.1032+9C>A intron_variant Intron 8 of 54 NP_001264198.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGENST00000399397.6 linkc.996+9C>A intron_variant Intron 9 of 55 5 NM_001292063.2 ENSP00000382329.2
OTOGENST00000399391.7 linkc.1032+9C>A intron_variant Intron 8 of 54 5 ENSP00000382323.2
OTOGENST00000485669.1 linkn.405-138C>A intron_variant Intron 2 of 2 4
OTOGENST00000498332.5 linkn.902+9C>A intron_variant Intron 8 of 15 5

Frequencies

GnomAD3 genomes
AF:
0.00706
AC:
1075
AN:
152212
Hom.:
9
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00188
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0142
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0113
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00694
AC:
1037
AN:
149360
AF XY:
0.00725
show subpopulations
Gnomad AFR exome
AF:
0.00131
Gnomad AMR exome
AF:
0.00233
Gnomad ASJ exome
AF:
0.00359
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0143
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.00692
GnomAD4 exome
AF:
0.00978
AC:
13681
AN:
1398188
Hom.:
77
Cov.:
32
AF XY:
0.00959
AC XY:
6613
AN XY:
689588
show subpopulations
African (AFR)
AF:
0.00130
AC:
41
AN:
31590
American (AMR)
AF:
0.00222
AC:
79
AN:
35662
Ashkenazi Jewish (ASJ)
AF:
0.00450
AC:
113
AN:
25138
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35736
South Asian (SAS)
AF:
0.00294
AC:
233
AN:
79194
European-Finnish (FIN)
AF:
0.0158
AC:
762
AN:
48300
Middle Eastern (MID)
AF:
0.00263
AC:
15
AN:
5700
European-Non Finnish (NFE)
AF:
0.0111
AC:
11970
AN:
1078830
Other (OTH)
AF:
0.00806
AC:
468
AN:
58038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
741
1482
2224
2965
3706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00705
AC:
1074
AN:
152330
Hom.:
9
Cov.:
33
AF XY:
0.00725
AC XY:
540
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00188
AC:
78
AN:
41574
American (AMR)
AF:
0.00255
AC:
39
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4830
European-Finnish (FIN)
AF:
0.0142
AC:
151
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0113
AC:
772
AN:
68018
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
54
108
163
217
271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00981
Hom.:
0
Bravo
AF:
0.00645
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 26, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

1032+9C>A in intron 8 of OTOG: This variant is not expected to have clinical sig nificance because it is not located within the conserved splice consensus sequen ce. It has been identified in 1.5% (11/758) of European chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.gov/projects/SN P; dbSNP rs147843540). -

OTOG-related disorder Benign:1
Feb 05, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
11
DANN
Benign
0.65
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147843540; hg19: chr11-17579871; API